# To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets

> **NCT00913224** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 38 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** Diclofenac Sodium 50 mg Tablets (Geneva Pharmaceuticals, Inc)
- **DRUG:** Voltaren 50 mg Tablets (Geigy Pharmaceuticals)

## Key facts

- **NCT ID:** NCT00913224
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-04
- **Primary completion:** 1993-04
- **Final completion:** 1993-04
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913224, "To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00913224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*